Contents

Active Ingredients

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

At Ergobyte we create software solutions that empower health professionals by assisting them with clinical and
pharmaceutical information at the point of care. GalenReasoner® does not provide medical advice, diagnosis or
treatment; it is intended for informational purposes only. We process personal data in accordance with the
General Data Protection Regulation.